Explore evidence

69 %Seventy-eight (69.0%) of the patients with diabetes had dyslipidemia.

Cameroundiabète (non précisé) · dyslipidemiaobserved 2019published 2022The Pan African medical journaleurope_pmcdocument of 10 observations

6.5 %The age-standardized diabetes prevalence using WHO criteria was 6.5% in men in Jamaica.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

5 yearsThe median duration of diabetes was 5 years (interquartile range: 3–10 years).

Cameroundiabète (non précisé)published 2021Cureuseurope_pmcdocument of 9 observations

8.5 %The age-standardized diabetes prevalence using WHO criteria was 8.5% in Jamaica.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

6 %Cameroon population has an estimated 6% affected by diabetes.

Cameroundiabète (non précisé)published 2016BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-016-3090-1

47.6 %Insulin could be discontinued in 47.6% of insulin-treated patients with adequate glycaemic control (HbA1c 6.7 +/- 1.3%).

Cameroundiabète (non précisé)published 2002Diabetic medicine : a journal of the British Diabetic Associationeurope_pmcdocument of 5 observations

2 %The age-standardized diabetes prevalence using WHO criteria was 2.0% in urban Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

0.8 %The age-standardized diabetes prevalence using WHO criteria was 0.8% in rural Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

41.6 %Prevalence of diabetes based on HbA1c was higher than prevalence based on FPG in 41.6% of age-sex-survey groups.

Cameroundiabète (non précisé)published 2015The lancet. Diabetes & endocrinologyeurope_pmcdocument of 5 observationsDOI 10.1016/s2213-8587(15)00129-1

3.4 %The age-standardized prevalence of diabetes increased from 3.4% to 8.5% in men in sub-Saharan African countries between 1980 and 2014.

Cameroundiabète (non précisé)observed 1980published 2017International journal of epidemiologyeurope_pmcdocument of 11 observationsDOI 10.1093/ije/dyx078

0.5 %The age-standardized diabetes prevalence using WHO criteria was 0.5% in women in rural Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

9,018 individualsSystolic blood pressure, diastolic blood pressure, and mean arterial pressure were associated with prevalent diabetes among 9018 Cameroonian adults.

Cameroundiabète (non précisé)published 2016Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument of 3 observations

1 %The age-standardized diabetes prevalence using WHO criteria was 1.0% in men in urban Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

57 %In the urban area of Cameroon, 57% of diabetic subjects were previously unknown before the survey.

Cameroundiabète (non précisé)published 1997Diabetologiaeurope_pmcdocument of 12 observationsDOI 10.1007/s001250050755

5 %Diabetes prevalence in lower-middle income countries in the Africa Region (AFR) was 5.0%.

Cameroundiabète (non précisé)published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations

11.5 %Among 676 participants, diabetes prevalence was 11.5%.

Cameroundiabète (non précisé)published 2022Scientific reportseurope_pmcdocument of 3 observationsDOI 10.1038/s41598-022-07328-8

8.7 %Among the 173 diabetic participants, 15 (8.7%) were positive for HHV8 DNA.

Cameroundiabète (non précisé) · HHV8published 2018Journal of diabeteseurope_pmcdocument of 10 observations

In the study by Sap et al. (2019), HbA1c levels at 3 months showed significant improvement in glycaemic control in the intervention group.

Cameroundiabète (non précisé)observed 2019HAL · Unilimdocument of 50 observations

1.6 %The age-standardized prevalence of diabetes in the urban population of Cameroon was 1.6% for women.

Cameroundiabète (non précisé)published 1997Diabetologiaeurope_pmcdocument of 12 observationsDOI 10.1007/s001250050755

C-peptide and homeostatic model assessment of β-cell function (HOMA-β) were significantly lower in HHV8 DNA-positive than HHV8 DNA-negative participants.

Cameroundiabète (non précisé) · HHV8published 2018Journal of diabeteseurope_pmcdocument of 10 observations

130 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol were less than 130 deaths per 100 000 for women in Canada.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobserved 2010published 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument of 28 observationsDOI 10.1016/s2213-8587(14)70102-0

The prevalence of diabetes mellitus is higher in HIV-positive persons compared to the general population.

Cameroundiabète (non précisé) · VIH/sidapublished 2018Current diabetes reportseurope_pmcdocument of 2 observations

11.6 %The glycemic index for pistachio sauce with foofoo corn was 11.60%.

Cameroundiabète (non précisé) · obésitépublished 2015Clinical diabetes and endocrinologyeurope_pmcdocument of 6 observations

13.1 %The glycemic index for the yellow sauce with foofoo corn was 13.10%.

Cameroundiabète (non précisé) · obésitépublished 2015Clinical diabetes and endocrinologyeurope_pmcdocument of 6 observations

30 %In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes).

Cameroundiabète (non précisé)observed 2014published 2016Lancet (London, England)europe_pmcdocument of 7 observationsDOI 10.1016/s0140-6736(16)00618-8